»» Searching for " polyomavirus "
 Related Search Tags:  NYSE:DGX DGX Biogen Leukoencephalopathy Polyomavirus STRATIFY-JCV
Showing Results 1-1 of 1 |  Sort by:     
Page 1 of 1  |  Go to page   
Quest Diagnostics Inc - DGX - reported that the FDA has granted a de novo classification petition to its STRATIFY JCV Antibody ELISA testing service. STRATIFY JCV is the first blood test to be FDA market authorized for the qualitative detection of antibodies to the polyomavirus JC virus for stratifying risk for progressive multifocal leukoencephalopathy, an infrequent but serious brain infection, in patients with multiple sclerosis receiving TYSABRI (natalizumab), a highly effective therapy for relapsing forms of multiple sclerosis. Based on exclusive collaboration with Biogen Idec, the test is only available in the United States through Quest Diagnostics’ Focus Diagnostics lab. Quest Diagnostics provides diagnostic testing, information, and services in the United States and internationally.rnrn*********************************rnrnTHIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY! (Read the Full Disclaimer at http://www.crwenewswire.com/disclaimer)rn
(DGX) Stratify JCV gets de...
Categories: Videos 
Added: 122 days ago
By: karmastock
Runtime: 1m24s
Views: 31
 | Comments: 0
Not yet rated
Page 1 of 1  |  Go to page   
About Us   |   Terms of Use   |   Privacy Policy   |   Copyright Notes   |   Contact Us   |   Help   |      |   Back to the top of this page
Copyright © 2006-2007 bongoTYube. All rights reserved.    | Page created in 0.0439 seconds.